参考文献/References:
[1] Liu N, Sheng X, Liu Y, et al. Increased CD70 expression is associated with clinical resistance to cisplatin-based che-motherapy and poor survival in advanced ovarian carcino-mas [J]. Onco Tar Ther, 2013, 6: 615-619.
[2] Iqbal SG. CD70 as a therapeutic target in human malignan-cies [J]. Expert Opin Ther Tar, 2008, 12: 341-51.
[3] 滕田璐，孔英君，孙文学，等. 肿瘤坏死因子CD70在肿瘤发生与治疗中的研究进展[J]. 现代肿瘤医学，2018，26（6）：971-975.
[4] 唐重阳，葛海涛，林志国，等. 失控的CD70在脑胶质瘤的发生与治疗中的潜在作用 [J]. 现代生物医学进展，2016，16（7）：1363-1365.
[5] 吴 瑗. CD70在肿瘤治疗中的研究进展[J]. 肿瘤，2013，33（2）：197-201.
[6] Emma JG, Simone N, Sneha S, et al. The role of CD27 in anti-viral T-cell immunity [J]. Curr Opin Virol, 2017, 22: 77-88.
[7] Melanie R, Christiane M, Anna MN, et al. pVHL/HIF-regu-lated CD70 expression is associated with infiltration of CD27+ lymphocytes and increased serum levels of solubleCD27 in clear cell renal cell carcinoma [J]. Clin Cancer Res, 2015, 21(4): 889-898.
[8] Ostrom QT, Haley G, Gabrielle T, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the united states in 2011-2015 [J]. Neuro-Oncol, 2018, 20(s4): 1-86.
[9] Linchun J, Haitao G, Yu L, et al. CD70, a novel target of CAR T-cell therapy for gliomas [J]. Neuro-Oncol, 2018, 20(1): 55-65.
[10] Steffen A, Jorg W, Manuel F, et al. Immune stimulatory effects of CD70 override CD70-mediated immune cell apoptosis in rodent glioma models and confer long-lasting antiglioma immunity in vivo [J]. Int J Cancer, 2006, 118(7): 1728-1735.
[11] Haitao G, Luyan M, Linchun J, et al. Tumor associated CD70expression is involved in promoting tumor migration and macrophage infiltration in GBM [J]. Int J Cancer, 2017, 141(7): 1434-1444.
[12] Miller JE, Tabatabai G. Soluble CD70: a novel im-muno-therapeutic agent for experimental glioblastoma: laboratory investigation [J]. J Neurosurg, 2010, 113(2): 280-285.
[13] Mario LS, Esther R, Shawn MG, et al. Reconstructing and reprogramming the tumor-propagating potential of glioblas-toma stem-like cells [J]. Cell, 2014, 157(3): 580-594.
[14] Wischhusen JJ, Radovanovic I. Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastoma [J]. Can-cerres, 2002, 62(9): 2592-2599.
[15] Jacobs J, Deschoolmeester V, Zwaenepoel K, et al. CD70: an emerging target in cancer immunotherapy [J]. Pharma-col Therapeut, 2015, 155: 1-10.
[16] 王 镔，赵 刚. 脑胶质瘤免疫治疗的进展与展望[J]. 中国微侵袭神经外科杂志，2018，23（11）: 523-526.
相似文献/References:
[1]陈正和 陈忠平.高级别胶质瘤的治疗现状及思考[J].中国临床神经外科杂志,2016,(06):350.[doi:10.13798/j.issn.1009-153X.2016.06.010]
[2]付 锴 江普查 宫 睿 王 伟.表达VASH1基因的人脑胶质瘤U-87MG细胞对化疗药物敏感性的变化[J].中国临床神经外科杂志,2016,(01):34.[doi:10.13798/j.issn.1009-153X.2016.01.012]
FU Kai,JIANG Pu-cha,GONG Rui,et al.Effect of lentiviral vector-mediated VASH1 gene on chemosensitivity of human glioma U-87MG cells[J].,2016,(03):34.[doi:10.13798/j.issn.1009-153X.2016.01.012]
[3]袁凡恩 综述 陈谦学 审校.胶质瘤干细胞的研究进展[J].中国临床神经外科杂志,2016,(08):508.[doi:10.13798/j.issn.1009-153X.2016.08.025]
[4]崔焕喜,柳 琛.多模态MRI、神经导航和超声在脑胶质瘤术中的应用[J].中国临床神经外科杂志,2016,(11):721.[doi:10.13798/j.issn.1009-153X.2016.11.027]
[5]闫 珊 徐善才.多学科护理照顾模式对脑胶质瘤术后病人自我护理能力的影响[J].中国临床神经外科杂志,2017,(05):352.[doi:10.13798/j.issn.1009-153X.2017.05.026]
YAN Shan,XU Shan-cai..Effects of multi-subjects nursing care model on self-care ability in patients with brain glioma after operation[J].,2017,(03):352.[doi:10.13798/j.issn.1009-153X.2017.05.026]
[6]罗似亮 夏之柏.脑胶质瘤病人脑脊液Midkine表达的临床意义[J].中国临床神经外科杂志,2017,(06):416.[doi:10.13798/j.issn.1009-153X.2017.06.017]
LUO Si-liang,XIA Zhi-bo..Clinical meanings of midkine expression in cerebrospinal fluid of patients with gliomas[J].,2017,(03):416.[doi:10.13798/j.issn.1009-153X.2017.06.017]
[7]杜霞 综述,刁波 审校.多形性胶质母细胞瘤的免疫治疗[J].中国临床神经外科杂志,2017,(07):514.[doi:10.13798/j.issn.1009-153X.2017.07.027]
[8]呼铁民 褚会松 田 甜 王昆鹏 杨国军 杨立军 王维兴.脑胶质瘤ADAM17与EGFR的表达及临床意义[J].中国临床神经外科杂志,2017,(08):557.[doi:10.13798/j.issn.1009-153X.2017.08.012]
HU Tie-min,CHU Hui-song,TIAN Tian,et al.Expressions of ADAM17 and EGFR in gliomas tissues and their clinical meanings[J].,2017,(03):557.[doi:10.13798/j.issn.1009-153X.2017.08.012]
[9]汪超甲 综述 王 辉 审校.脑胶质瘤化疗现状及耐药机制的研究进展[J].中国临床神经外科杂志,2017,(11):791.[doi:10.13798/j.issn.1009-153X.2017.11.023]
[10]高剑峰 姚庆和 李晓辉 龙宇波 陈振波.脑胶质瘤miR-9、PPARγ表达水平及临床意义[J].中国临床神经外科杂志,2018,(01):17.[doi:10.13798/j.issn.1009-153X.2018.01.006]
GAO Jian-feng,YAO Qing-he,LI Xiao-hui,et al.Expressions of miR-9 and PPARγ in human brain gliomas and their clinical meanings[J].,2018,(03):17.[doi:10.13798/j.issn.1009-153X.2018.01.006]